Literature DB >> 32235058

Multi-view radiomics and dosiomics analysis with machine learning for predicting acute-phase weight loss in lung cancer patients treated with radiotherapy.

Sang Ho Lee1, Peijin Han1, Russell Hales2, K Ranh Voong1, Kazumasa Noro3, Shinya Sugiyama3, John W Haller4, Todd McNutt1, Junghoon Lee1.   

Abstract

We propose a multi-view data analysis approach using radiomics and dosiomics (R&D) texture features for predicting acute-phase weight loss (WL) in lung cancer radiotherapy. Baseline weight of 388 patients who underwent intensity modulated radiation therapy (IMRT) was measured between 1 month prior to and 1 week after the start of IMRT. Weight change between 1 week and 2 months after the commencement of IMRT was analyzed, and dichotomized at 5% WL. Each Patient had a planning CT and contours of gross tumor volume (GTV) and esophagus (ESO). A total of 355 features including clinical parameter (CP), GTV and ESO (GTV&ESO) dose-volume histogram (DVH), GTV radiomics, and GTV&ESO dosiomics features were extracted. R&D features were categorized as first- (L1), second- (L2), higher-order (L3) statistics, and three combined groups, L1+L2, L2+L3 and L1+L2+L3. Multi-view texture analysis was performed to identify optimal R&D input features. In the training set (194 earlier patients), feature selection was performed using Boruta algorithm followed by collinearity removal based on variance inflation factor. Machine-learning models were developed using Laplacian kernel support vector machine (lpSVM), deep neural network (DNN) and their averaged ensemble classifiers. Prediction performance was tested on an independent test set (194 more recent patients), and compared among 7 different input conditions: CP-only, DVH-only, R&D-only, DVH+CP, R&D+CP, R&D+DVH and R&D+DVH+CP. Combined GTV L1+L2+L3 radiomics and GTV&ESO L3 dosiomics were identified as optimal input features, which achieved the best performance with an ensemble classifier (AUC=0.710), having statiscially significantly higher predictability compared with DVH and/or CP features (p<0.05). When this performance was compared to that with full R&D-only features which reflect traditional single-view data, there was a statistically significant difference (p<0.05). Using optimized multi-view R&D input features is beneficial for predicting early WL in lung cancer radiotherapy, leading to improved performance compared to using conventional DVH and/or CP features.
© 2020 Institute of Physics and Engineering in Medicine.

Entities:  

Keywords:  IMRT; dosiomics; lung cancer; machine learning; radiomics; radiotherapy; weight loss

Year:  2020        PMID: 32235058     DOI: 10.1088/1361-6560/ab8531

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  5 in total

Review 1.  Review of Radiomics- and Dosiomics-based Predicting Models for Rectal Cancer.

Authors:  Yun Qin; Li-Hua Zhu; Wei Zhao; Jun-Jie Wang; Hao Wang
Journal:  Front Oncol       Date:  2022-08-09       Impact factor: 5.738

2.  Multiblock Discriminant Analysis of Integrative 18F-FDG-PET/CT Radiomics for Predicting Circulating Tumor Cells in Early-Stage Non-small Cell Lung Cancer Treated With Stereotactic Body Radiation Therapy.

Authors:  Sang Ho Lee; Gary D Kao; Steven J Feigenberg; Jay F Dorsey; Melissa A Frick; Samuel Jean-Baptiste; Chibueze Z Uche; Keith A Cengel; William P Levin; Abigail T Berman; Charu Aggarwal; Yong Fan; Ying Xiao
Journal:  Int J Radiat Oncol Biol Phys       Date:  2021-03-01       Impact factor: 8.013

3.  Radiomics and Dosiomics for Predicting Local Control after Carbon-Ion Radiotherapy in Skull-Base Chordoma.

Authors:  Giulia Buizza; Chiara Paganelli; Emma D'Ippolito; Giulia Fontana; Silvia Molinelli; Lorenzo Preda; Giulia Riva; Alberto Iannalfi; Francesca Valvo; Ester Orlandi; Guido Baroni
Journal:  Cancers (Basel)       Date:  2021-01-18       Impact factor: 6.639

4.  Multi-Organ Omics-Based Prediction for Adaptive Radiation Therapy Eligibility in Nasopharyngeal Carcinoma Patients Undergoing Concurrent Chemoradiotherapy.

Authors:  Sai-Kit Lam; Yuanpeng Zhang; Jiang Zhang; Bing Li; Jia-Chen Sun; Carol Yee-Tung Liu; Pak-Hei Chou; Xinzhi Teng; Zong-Rui Ma; Rui-Yan Ni; Ta Zhou; Tao Peng; Hao-Nan Xiao; Tian Li; Ge Ren; Andy Lai-Yin Cheung; Francis Kar-Ho Lee; Celia Wai-Yi Yip; Kwok-Hung Au; Victor Ho-Fun Lee; Amy Tien-Yee Chang; Lawrence Wing-Chi Chan; Jing Cai
Journal:  Front Oncol       Date:  2022-01-31       Impact factor: 6.244

Review 5.  Deep Learning With Radiomics for Disease Diagnosis and Treatment: Challenges and Potential.

Authors:  Xingping Zhang; Yanchun Zhang; Guijuan Zhang; Xingting Qiu; Wenjun Tan; Xiaoxia Yin; Liefa Liao
Journal:  Front Oncol       Date:  2022-02-17       Impact factor: 6.244

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.